“Ice Cream Man,” Eli Roth‘s new horror film, has sold several key international rights to StudioCanal’s Sixth Dimension. The acquisition marks the first major transaction for the film out ...

Meanwhile, Eli Lilly's Zepbound injection has gained traction, prompting both firms to race toward more convenient weight?loss pills. Investors will watch upcoming trial readouts and regulatory ...

Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...

Media Capital Technologies (MCT) and The Horror Section will fully finance and produce “Ice Cream Man,” Eli Roth’s new horror film. Roth, a master of the genre whose work includes the ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)'s share was trading ...

U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282, an early-stage therapeutic candidate targeting amyotrophic lateral ...

The new threat has Eli Lilly investors running scared, but Wall Street analysts insist Eli Lilly stock is still a buy. GLP-1 drug prices are falling. That's good news for patients, but perhaps not ...

Eli Lilly is up 2.3% since the beginning of the year, but at $796.33 per share, it is still trading 17.1% below its 52-week high of $960.02 from August 2024. Investors who bought $1,000 worth of ...

Michael Nagle / Bloomberg via Getty Images Shares of Eli Lilly (LLY) fell sharply Thursday morning after the pharmaceutical giant's lowered profit projections outweighed first-quarter results that ...

Eli Lilly's Q1 numbers showed strong revenue and earnings growth, driven by its GLP-1 offerings. The company's 2025 outlook disappointed investors, however, leading to the decline. The stock ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on tariffs on the industry. Trump's Department of Commerce is looking into ...

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, but its stock sank more than 11% in trading despite the win. The ...